Latest News

Why Freehold Royalties Is Back on Investors’ Radar Interest in Freehold Royalties (TSX:FRU) has picked up as investors look for energy exposure that emphasizes income. The company collects oil and gas royalties, which can reduce direct operating risk compared with producers. See our latest analysis for Freehold Royalties. At a share price of CA$14.89, Freehold Royalties has seen short term share price softness. However, its 9.81% 90 day share price return and 20.69% one year total shareholder...

Leonardo DRS, Inc. recently appointed long-time executive Sally A. Wallace as Executive Vice President and Chief Operating Officer, succeeding new President and CEO John Baylouny as part of a broader leadership transition at the defense electronics company. This elevation of a veteran insider with deep operational and technical credentials signals continuity in execution as Leonardo DRS pursues advanced defense technology programs and international collaborations. We’ll now examine how...

If you are wondering whether Globalstar's recent share price is still good value or already stretched, the next sections will walk through what the current market price might be implying. The stock has had a choppy run, with a 2.1% decline over the last week, a 12.4% decline over the last month, a 6.6% decline year to date, a 101.2% gain over the last year, and a 174.8% return over three years. These moves sit against growing investor interest in satellite connectivity and related telecom...

Biogen (BIIB) is back in focus after Chinese regulators accepted the Biologics License Application for a subcutaneous version of LEQEMBI, highlighting a potential shift toward more convenient Alzheimer’s treatment and influencing recent sentiment around the stock. See our latest analysis for Biogen. The LEQEMBI update lands after a strong 90-day share price return of 26.90% and a 30-day share price return of 5.78%, while the 1-year total shareholder return of 23.38% contrasts with weaker 3...

In early January 2026, Marathon Petroleum drew attention after recent U.S. actions toward Venezuela raised the prospect of greater heavy-crude flows that Gulf Coast refiners, including Marathon’s large Garyville facility, are well equipped to process. Investors are now weighing how Marathon’s ability to handle additional Venezuelan heavy crude could interact with its existing refining advantages and upcoming fourth-quarter 2025 earnings announcement. Next, we’ll examine how Marathon’s...

If you are wondering whether Fresh Del Monte Produce at around US$35.66 is offering good value today, this article will walk you through how the current share price lines up against different measures of worth. The stock has had a mixed run recently, with a 0.1% move over the past week, a 3.0% decline over the last 30 days, a 1.0% gain year to date, and a 18.7% return over 1 year, extending to 42.9% over 3 years and 65.5% over 5 years. Recent attention on Fresh Del Monte Produce has focused...

Anywhere Real Estate: Recent Performance Snapshot Anywhere Real Estate (HOUS) has been catching investor attention after a sharp move in its share price, with recent returns standing at 3.6% over the past day and 24.6% across the past week. Those short term gains sit alongside a month return of 20% and an approximately 87% move over the past 3 months, putting the current share price at US$17.64 as of the latest close. See our latest analysis for Anywhere Real Estate. Looking beyond the recent...

Onto Innovation recently announced that CEO Michael Plisinski and CFO Brian Roberts participated in the 28th Annual Needham Growth Conference in New York, offering a webcast fireside chat and one‑on‑one investor meetings whose materials remain available on the company’s investor relations site. This outreach, alongside increasingly positive commentary from multiple analysts on semiconductor equipment demand and Onto Innovation’s business fundamentals, has helped sharpen investor focus on the...

Earlier this week, Bank of America Securities reaffirmed a positive analyst rating on Boston Scientific and highlighted progress in its Global Pulsed Field Ablation Trial targeting persistent atrial fibrillation. This focus on pulsed field ablation underscores how Boston Scientific is positioning its electrophysiology portfolio around minimally invasive treatments for complex cardiac rhythm disorders. We’ll now examine how upbeat analyst sentiment around electrophysiology demand and pulsed...

If you are wondering whether OSI Systems at around US$279.61 is offering fair value or stretching expectations, this breakdown is designed to help you size that up with clear numbers. The stock has posted returns of 9.6% over the last 7 days, 7.4% over the last 30 days, 9.4% year to date, 77.3% over 1 year, 224.4% over 3 years, and 194.4% over 5 years, which naturally raises questions about what is already reflected in the current price. Recent coverage has focused on OSI Systems as a...

Fresh commentary around U.S. cannabis rescheduling has put Innovative Industrial Properties (IIPR) back in focus, as investors weigh what stronger tenant credit profiles could mean for its dividend coverage and preferred share payouts. See our latest analysis for Innovative Industrial Properties. That backdrop helps explain why the stock’s recent momentum has been mixed, with a 7 day share price return of 5.28% alongside a 1 year total shareholder return of 12.52%, and deeper 3 year and 5...

Franco-Nevada (TSX:FNV) is back in focus after ongoing royalty disputes and a production halt at a key Latin American asset continued to weigh on sentiment, keeping attention squarely on its near term revenue outlook. See our latest analysis for Franco-Nevada. Despite the royalty dispute and production suspension weighing on sentiment, Franco-Nevada’s recent 1-day, 7-day and 30-day share price returns of 3.71%, 9.89% and 11.26% respectively suggest momentum is improving. In addition, 1-year...

IDEXX Laboratories recently prepared to release its fiscal Q4 2025 results, with analysts highlighting ongoing profit strength supported by its Companion Animal Group Diagnostics segment and growing demand for diagnostic instruments and cloud-based software. Analysts’ consistently optimistic earnings expectations and the company’s track record of surpassing profit estimates have reinforced confidence in the resilience of IDEXX’s diagnostics-led business model. Now, we’ll examine how optimism...

If you are wondering whether Morgan Stanley's share price still offers value after a strong run, this article will help you frame that question clearly. The stock recently closed at US$184.68, with returns of 4.0% over 7 days, 3.3% over 30 days, 1.5% year to date, 48.5% over 1 year, 125.8% over 3 years, and 183.3% over 5 years. Recent coverage has focused on Morgan Stanley's position as a major US diversified financials group, with attention on how global deal activity, wealth management...

PriceSmart (PSMT) has just opened its 2026 financial year with Q1 same store sales growth of 8%, coming on the heels of Q4 2025 revenue of US$1.3 billion and basic EPS of US$1.02, alongside trailing twelve month EPS of US$4.82 on revenue of US$5.3 billion. The company has seen quarterly revenue move from US$1.26 billion in Q1 2025 to US$1.36 billion in Q2, then US$1.32 billion in Q3 and US$1.33 billion in Q4, while basic EPS over that stretch ranged from US$1.21 to US$1.45. This sets up Q1...

In late 2025, Intesa Sanpaolo finalized a €700 million financing agreement with the European Investment Bank to lower funding costs and expand lending to Italian SMEs and energy transition projects. This partnership highlights how Intesa Sanpaolo is using multilateral funding to support priority sectors while potentially reinforcing its role in Italy’s credit ecosystem. We’ll now examine how this new EIB financing line for SME and energy-transition lending may influence Intesa Sanpaolo’s...

If you are wondering whether Neurocrine Biosciences, at around its recent US$135.57 share price, offers value, you are not alone. This article is designed to help you frame that question clearly before you make up your own mind. The stock has seen mixed returns, with a 4.4% decline over the past 7 days, a 12.5% decline over 30 days, a 3.6% decline year to date, a 2.3% decline over 1 year, but gains of 23.8% over 3 years and 24.0% over 5 years. Recent attention on Neurocrine Biosciences has...

Franklin Covey (FC) opened fiscal Q1 2026 with revenue of US$64.0 million and a basic EPS loss of US$0.27, alongside net income excluding extraordinary items of a US$3.3 million loss, setting a cautious tone for the new financial year. The company has seen quarterly revenue move from US$69.1 million in Q1 2025 to US$84.1 million in Q4 2024 and US$64.0 million in Q1 2026, while basic EPS has ranged from a profit of US$0.92 in Q4 2024 to a loss of US$0.27 in the latest quarter, which puts the...

Earlier this week, Bank of America Securities downgraded Sigma Lithium from Neutral to Underperform, citing unresolved operational delays, liquidity uncertainty, and limited clarity on when mining operations will restart. The downgrade underscores a growing disconnect between improved lithium market fundamentals and Sigma Lithium’s stalled production progress and delayed project timelines. Next, we’ll examine how Bank of America’s concerns about unresolved operational delays could reshape...

Wondering if Paramount Skydance at US$12.27 offers value or just more volatility? This article walks through what the current price actually reflects about the business. The stock is down 8.4% over the last week and 16.2% over the last month, while the 1 year return sits at 17.1% and the 5 year return at a 70.0% decline, which can change how investors think about both upside and risk. Recent coverage has focused on Paramount and Skydance completing their merger, the reshaped ownership...

Allison Transmission Holdings (ALSN) has been under scrutiny as recent commentary points to a challenging demand backdrop, with anticipated sales decline and slower revenue and earnings growth than industrial peers weighing on sentiment. See our latest analysis for Allison Transmission Holdings. The recent executive reshuffle and the acquisition of Dana’s Off-Highway Drive & Motion Systems have arrived alongside a 90 day share price return of 28.58% and a 30 day share price return of 9.03%...

With no single headline event driving attention today, American States Water (AWR) is drawing interest as investors weigh its recent share performance against its current earnings profile and regulated utility footprint in California. See our latest analysis for American States Water. The recent 1-day and 30-day share price returns of 0.52% and 1.45% respectively contrast with a 2.10% decline over 90 days. The 1-year total shareholder return of 2.52% sits against a weaker 3-year total...

In December, Goldman Sachs downgraded Illinois Tool Works to Sell from Neutral, even as the company posted a record 27.4% operating margin in Q3 2025 and reaffirmed its full-year operating margin and EPS guidance. This mix of bearish analyst sentiment and resilient profitability highlights a tension between perceived valuation limits and management’s confidence in the underlying business. Next, we’ll examine how Goldman Sachs’ Sell call, set against Illinois Tool Works’ record margins and...

If you are wondering whether Vital Farms shares are offering fair value at around US$30.06, the key question is how its current price compares with what the business might be worth. The stock has been volatile, with a 5.9% decline over the last 7 days, a 9.8% decline over the last 30 days, a 0.8% gain year to date and a 23.7% decline over the last year. The 3 year and 5 year returns sit at 89.7% and 17.9% respectively. These mixed returns have kept Vital Farms on the radar for investors who...